LTRN•benzinga•
Recap: Lantern Pharma Q1 Earnings
Summary
Lantern Pharma (NASDAQ:LTRN) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Lantern Pharma missed estimated earnings by 31.03%, reporting an EPS of $-0.38 versus an estimate of $-0.29.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 3, 2022 by benzinga